AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hermab 440mg Injection

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Trastuzumab (440mg)

Overview Hermab 440mg Injection

Trastuzumab 440mg injection is indicated for treating breast and gastric cancers. Its mechanism involves targeted cancer cell destruction via HER2 receptor inhibition. Administration is strictly by injection from a qualified healthcare provider. Dosage frequency and duration are determined individually by your physician, based on your condition, and may vary. Adhere precisely to your doctor's instructions; improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits might not be apparent immediately; discontinue only under medical guidance. Frequently reported side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can suppress blood cell production (red and white blood cells), enhancing infection vulnerability. Regular blood tests monitoring blood cell counts, cardiac function, liver health, and uric acid levels are essential. Report immediately any shortness of breath, cough, chills, or limb swelling. Inform your healthcare team of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout treatment to prevent conception.

Uses of Hermab 440mg Injection

Cancers affecting the breast and stomach

Major Benefits of Hermab 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Hermab 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Hermab 440mg Injection:

This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.

How Hermab 440mg Injection works:

Hermab 440mg Injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—proteins on breast and stomach cancer cells that fuel uncontrolled cell growth. By binding to HER2, it neutralizes the receptors' activity, thereby eliminating cancer cells and disrupting crucial cancer-promoting signaling cascades.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Hermab 440mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Hermab 440mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in extreme, life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Hermab 440mg Injection while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Hermab 440mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Hermab 440mg Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary. However, physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Hermab 440mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Hermab 440mg Injection :

Should you forget a Hermab 440mg Injection dose, seek your physician's advice.

Facts to Know About Hermab 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Type of Therapy Cancer Therapeutics
Action Category Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Hermab 440mg Injection

Hermab 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bruising or bleeding. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Seek immediate medical attention if you experience any of these symptoms.
Women of childbearing age must use reliable contraception throughout Hermab 440mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Hermab 440mg Injection should be administered to early-stage breast cancer patients for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Hermab 440mg Injection doesn't require fasting beforehand. Administration must be supervised by an oncologist and performed only by a qualified healthcare professional.
Hermab 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the label to ensure correct administration. The IV formulation is for intravenous infusion only; it is not suitable for subcutaneous use. Your doctor may change your treatment between IV and SC Hermab 440mg Injection as needed.
Hermab 440mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Its mechanism involves binding to HER2, thus inhibiting cancer cell growth and spread. Consequently, this injection is only effective, and therefore indicated, for patients with HER2-positive cancer; it's ineffective in HER2-negative cases.
Using Hermab 440mg Injection with anthracyclines (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and during treatment.
Cardiac evaluations are necessary at treatment initiation, every three months during treatment, and every six months post-treatment for up to 24 months following the final Hermab 440mg Injection dose. Patients with pre-existing cardiac conditions require evaluation every twelve weeks.
Hermab 440mg Injection
47,111
MRP 54,663
13% off